1. Home
  2. PCVX vs DNB Comparison

PCVX vs DNB Comparison

Compare PCVX & DNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • DNB
  • Stock Information
  • Founded
  • PCVX 2013
  • DNB 1841
  • Country
  • PCVX United States
  • DNB United States
  • Employees
  • PCVX 414
  • DNB N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • DNB Finance: Consumer Services
  • Sector
  • PCVX Health Care
  • DNB Finance
  • Exchange
  • PCVX Nasdaq
  • DNB Nasdaq
  • Market Cap
  • PCVX 4.1B
  • DNB 4.0B
  • IPO Year
  • PCVX 2020
  • DNB 2020
  • Fundamental
  • Price
  • PCVX $35.02
  • DNB $9.03
  • Analyst Decision
  • PCVX Strong Buy
  • DNB Hold
  • Analyst Count
  • PCVX 10
  • DNB 6
  • Target Price
  • PCVX $136.50
  • DNB $11.43
  • AVG Volume (30 Days)
  • PCVX 2.5M
  • DNB 8.2M
  • Earning Date
  • PCVX 05-07-2025
  • DNB 05-01-2025
  • Dividend Yield
  • PCVX N/A
  • DNB 2.22%
  • EPS Growth
  • PCVX N/A
  • DNB N/A
  • EPS
  • PCVX N/A
  • DNB N/A
  • Revenue
  • PCVX N/A
  • DNB $2,397,000,000.00
  • Revenue This Year
  • PCVX N/A
  • DNB $4.72
  • Revenue Next Year
  • PCVX N/A
  • DNB $4.69
  • P/E Ratio
  • PCVX N/A
  • DNB N/A
  • Revenue Growth
  • PCVX N/A
  • DNB 2.52
  • 52 Week Low
  • PCVX $27.66
  • DNB $7.78
  • 52 Week High
  • PCVX $121.06
  • DNB $12.95
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 52.30
  • DNB 55.96
  • Support Level
  • PCVX $31.37
  • DNB $8.94
  • Resistance Level
  • PCVX $33.31
  • DNB $9.03
  • Average True Range (ATR)
  • PCVX 2.13
  • DNB 0.03
  • MACD
  • PCVX 0.77
  • DNB 0.00
  • Stochastic Oscillator
  • PCVX 77.80
  • DNB 92.86

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About DNB Dun & Bradstreet Holdings Inc.

Dun & Bradstreet Holdings Inc is a provider of business decisioning data and analytics. The company operates in two segments: North America, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights in the United States and Canada; and International, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights directly in the U.K, Europe, Greater China, India and indirectly through its WWN alliances. The company generates maximum revenue from the North American region. Other services provided by the company include digital marketing, sales acceleration, and risk management among others.

Share on Social Networks: